AGP Executive Report
Last update: 8 hours agoInflation & Health Costs: Singapore’s CPI rose 1.7% year-on-year in 1H 2026, with health insurance among the contributors; core inflation also picked up to 1.6% in June as food, services and retail costs edged higher. Public Health Watch: HSA warned consumers to stop buying three products after testing found banned or potent medicinal ingredients, following serious adverse effects reported by users including a 12-year-old. Workplace Safety: Seven people died in work-related traffic accidents in 1H 2026 (including four platform workers), prompting calls to tighten safety for routine tasks, not just high-risk work. Oncology & Biotech: Singapore-based Tikva Allocell raised $8m to push a B7-H3 cell therapy candidate toward Phase 1 trials in Singapore and the US. Wellness & Care Tech: A Woodlands Hospital pilot is reported to reduce hospitalisations and A&E visits for nursing home residents, pointing to more care-at-home models. Health Equity & Access: Singapore’s Cabinet reshuffle included leadership changes relevant to manpower and digital development, as the government continues its leadership transition.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
